124 related articles for article (PubMed ID: 15988791)
1. Multicentre validation study of sentinel node biopsy for staging in breast cancer.
Bergkvist L; Frisell J; ;
Br J Surg; 2005 Oct; 92(10):1221-4. PubMed ID: 15988791
[TBL] [Abstract][Full Text] [Related]
2. Removal of two sentinel nodes accurately stages the axilla in breast cancer.
Kennedy RJ; Kollias J; Gill PG; Bochner M; Coventry BJ; Farshid G
Br J Surg; 2003 Nov; 90(11):1349-53. PubMed ID: 14598413
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node biopsy for breast cancer larger than 3 cm in diameter.
Schüle J; Frisell J; Ingvar C; Bergkvist L
Br J Surg; 2007 Aug; 94(8):948-51. PubMed ID: 17436338
[TBL] [Abstract][Full Text] [Related]
4. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
5. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract][Full Text] [Related]
6. Detection of micrometastases in lymph nodes from patients with breast cancer.
Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
[TBL] [Abstract][Full Text] [Related]
7. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do.
Behm EC; Buckingham JM
ANZ J Surg; 2008 Mar; 78(3):151-7. PubMed ID: 18269478
[TBL] [Abstract][Full Text] [Related]
9. A decision tool for predicting sentinel node accuracy from breast tumor size and grade.
Coombs N; Chen W; Taylor R; Boyages J
Breast J; 2007; 13(6):593-8. PubMed ID: 17983402
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer.
Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V
Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061
[TBL] [Abstract][Full Text] [Related]
11. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
12. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
14. Technical limitations of sentinel node biopsy in breast cancer: a single surgeon's experience.
Patel NA; Dusi D; Bragdon G; Julian TB
Am Surg; 2003 Feb; 69(2):111-6. PubMed ID: 12641350
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
17. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.
Bergkvist L; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Frisell J;
Ann Surg; 2008 Jan; 247(1):150-6. PubMed ID: 18156935
[TBL] [Abstract][Full Text] [Related]
18. [Feasibility of the sentinel node biopsy in breast cancer in case of histological multifocality diagnosis].
Bézu C; Coutant C; Antoine M; Moutafoff C; Guillo E; Daraï E; Rouzier R; Uzan S
Gynecol Obstet Fertil; 2009; 37(7-8):604-10. PubMed ID: 19577499
[TBL] [Abstract][Full Text] [Related]
19. The outcome of sentinel node biopsy in breast cancer patients with preoperative surgical biopsy.
Leidenius MH; Vironen JH; von Smitten KA; Heikkilä PS; Joensuu H
J Surg Oncol; 2009 Jun; 99(7):420-3. PubMed ID: 19350567
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer.
Chicken DW; Kocjan G; Falzon M; Lee AC; Douek M; Sainsbury R; Keshtgar MR
Br J Surg; 2006 May; 93(5):572-6. PubMed ID: 16550634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
